Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Gregory Lip

101-150 of 2739 results

View this query on the Wikidata Query Service
Stroke prevention in atrial fibrillation: An Asian perspective

scientific article published on February 6, 2014
Circulating endothelial cells in cardiovascular disease

scientific article published on 26 September 2006
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).

scientific article
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis

scientific article (publication date: April 2007)
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study

scientific article published on 9 June 2015
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta‐Analysis of Randomized Trials

scientific article published on May 1, 2014
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

scientific article published on 26 July 2011
Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis

scientific article published on September 2010
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

scientific article published on February 24, 2015
The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease

scientific article published on June 2011
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

scientific article
The role of monocytes and inflammation in the pathophysiology of heart failure

scientific article published on 27 September 2011
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure

scientific article published in February 2004
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation

scientific article published on 01 August 2012
Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk

scientific article published on March 2011
Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

scientific article published on 01 August 2011
The potential impact of periodontal disease on general health: a consensus view

scientific article published on 30 April 2008
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

scientific article published on August 30, 2011
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report

scientific article published on 22 August 2018
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

scientific article (publication date: June 2004)
Management of atrial fibrillation

scientific article published on 01 August 2007
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 28 February 2013
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors

scientific article published on 24 August 2017
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis

scientific article
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey

scientific article published on 28 January 2014
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes

scientific article published on 16 September 2004
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

scientific article
Hemoxygenase-1 in cardiovascular disease

scientific article published on September 2008
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

scientific article (publication date: 21 July 2004)
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

scientific article published in May 2017
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis

scientific article published on February 2008
Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project

scientific article published in January 2002
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes

scientific article published on 09 August 2004
Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making

scientific article published on 9 June 2017
The prevalence and persistence of depression and anxiety following myocardial infarction

scientific article published in February 2002
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).

scientific article
Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

scientific article published in 2013
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

scientific article published on 30 August 2014
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

scientific article published on 10 September 2007
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

scientific article
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

scientific article
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.

scientific article published on February 2017
Is hypertension an inflammatory process?

scientific article
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes

scientific article published on 01 February 2002
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

scientific article published in February 2012
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis

scientific article published on 19 August 2016
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention

scientific article
Endothelial dysfunction: methods of assessment and application to hypertension

scientific article

Paulina is supported by:

About Paulina

Help